Skip to main content
SpringerLink
Log in

Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

Background/Aims

Accurate assessment of renal function in patients with liver cirrhosis is difficult and of great prognostic importance. The present study aimed to determine the prognostic significance of certain renal markers and to investigate the priority of serum cystatin C (CysC) levels on one-year mortality in cirrhotic patients.

Methods

Renal function of 45 liver cirrhotic patientss was evaluated by levels of blood urea nitrogen (BUN), serum creatinine (Cr), CysC, as well as 24-hour creatinine clearance (CCl) and estimated glomerular filtration rate obtained by Cockroft-Gault and MDRD formulas. The endpoint of the follow up was mortality within one year. Spearman’s correlation, linear regression analysis and receiver operating characteristic curves were used to investigate prognostic factors.

Results

42 men and 3 women (mean age 53.18 ± 9.71 years) were enrolled in the study. Eleven of the patients (24.4%) died as a result of liver cirrhosis within one year. In predicting mortality, levels of BUN, serum Cr and CysC showed area under the curves (AUC) values of 0.719 (95% CI, 0.539–0.899, p = 0.03), 0.726 (95% CI, 0.541–0.911, p = 0.026) and 0.770 (95% CI, 0.620–0.920, p = 0.008). Sensitivity and specificity of a CysC level of >1.3 mg/l in predicting mortality were 72% and 68%, respectively. Univariate regression analysis showed that elevated levels of CysC above the referent ones, increased the risk of one-year mortality nearly six times (p = 0.02, Exp (B) = 5.81).

Conclusions

Serum CysC could be used as a good prognostic marker in patients with cirrhosis and normal Cr levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Garcia-Tsao G., Parikh C.R., Viola A. Acute kidney injury in cirrhosis. Hepatology, 2008, 48, 2064–2077

    Article  CAS  PubMed  Google Scholar 

  2. Arroyo V., Colmenero J. Ascites and hepatorenal syndrome in cirrhosis. J. Hepatol., 2003, 38, 69–89

    Article  Google Scholar 

  3. Arroyo V., Fernandez J., Gines P. Pathogenesis and treatment of hepatorenal syndrome. Semin. Liver Dis., 2008, 28, 81–95

    Article  PubMed  Google Scholar 

  4. Cholongitas E., Shusang V., Marelli L., Nair D., Thomas M., Patch D., Burns A., Sweny P., Burroughs A.K. Review article: renal function assessment in cirrhosis — difficulties and alternative measurements. Aliment. Pharmacol. Ther., 2007, 26, 969–971

    Article  CAS  PubMed  Google Scholar 

  5. Lopez-Hoyos M., San Segundo D., Benito M.J., Fernández-Fresnedo G., Ruiz J.C., Rodrigo E., Gómez-Alamillo C., Benito A., Arias M. Association between serum soluble CD30 and serum creatinine before and after renal transplantation. Transplant. Proc., 2008, 40, 2903–2905

    Article  CAS  PubMed  Google Scholar 

  6. Mishra J., Ma Q., Prada A., Mitsnefes M., Yang J., Barasch J., Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol., 2003,14, 2534–2543

    Article  CAS  PubMed  Google Scholar 

  7. Parikh C.R., Abraham E., Ancukiewicz M., Edelstein C.L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol., 2005, 16, 3046–3052

    Article  CAS  PubMed  Google Scholar 

  8. Bonventre J.V. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib. Nephrol., 2007, 156, 213–219

    Article  PubMed  Google Scholar 

  9. Newman D.J., Thakkar H., Edwards R.G., Wilkie M., White T., Grubb A.O., Price C.P. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int.,1995,47, 312–318

    Article  CAS  PubMed  Google Scholar 

  10. Randers E., Erlandsen E.J. Serum cystatin C as an endogenous marker of the renal function-a review. Clin. Chem. Lab. Med., 1999, 37, 389–395

    Article  CAS  PubMed  Google Scholar 

  11. Demirtas S., Bozbas A., Akbay A., Akbay A., Yavuz Y., Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin. Chim. Acta, 2001, 311, 81–89

    Article  CAS  PubMed  Google Scholar 

  12. Gerbes A.L., Gulberg V., Bilzer M., Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut, 2002, 50, 106–110

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Orlando R., Mussap M., Plebani M., Piccoli P., De Martin S., Floreani M., Padrini R., Palatini P. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin. Chem., 2002, 48, 850–858

    CAS  PubMed  Google Scholar 

  14. Kim D.J., Kang H.S., Choi H.S., Cho H.J., Kim S.E., Keum B., An H., Kim J.H., Seo S.Y., Kim Y.S., Yim H.J., Jeen Y.T., Lee H.S., Um S.H., Kim C.D., Ryu H.S. Serum cystatin c level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. The Korean Journal of Hepatology, 2011,17,130–138

    Article  PubMed Central  PubMed  Google Scholar 

  15. Chung M.Y., Jun D.W., Sung S.A. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. The Korean Journal of Hepatology,2010, 16, 301–307

    Article  PubMed Central  PubMed  Google Scholar 

  16. Ix J.H., Shlipak M.G., Chertow G.M., Whooley M.A. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation, 2007,115,173–179

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. De Boer I.H., Katz R., Cao J.J., Fried L.F., Kestenbaum B., Mukamal K., Rifkin D.E., Sarnak M.J., Shlipak M.G., Siscovick D.S. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care, 2009, 32,1833–1838

    Google Scholar 

  18. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg., 1973, 60, 646–649

    Article  CAS  PubMed  Google Scholar 

  19. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., Kremers W., Lake J., Howard T., Merion R.M., Wolfe R.A., Krom R. Model for end-stage liver disease MELD and allocation of donor livers. Gastroenterology 2003,124, 91–96

    Article  PubMed  Google Scholar 

  20. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron, 1976, 16, 31–41

    Article  CAS  PubMed  Google Scholar 

  21. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med., 1999, 130, 461–470

    Article  CAS  PubMed  Google Scholar 

  22. Proulx N.L., Akbari A., Garg A.X., Rostom A., Jaffey J., Clark H.D. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol. Dial. Transplant,2005,20,1617–1622

    Article  CAS  PubMed  Google Scholar 

  23. Seo Y.S., Jung E.S., An H., Kim J.H., Jung Y.K., Kim J.H., Yim H.J., Yeon J.E., Byun K.S., Kim C.D., Ryu H.S., Um S.H. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int.,2009,29,1521–1527

    Article  CAS  PubMed  Google Scholar 

  24. Fernández-Esparrach G., Sánchez-Fueyo A., Ginès P., Uriz J., Quinto L., Ventura P.J., Cardenas A., Guevara M., Sort P., Jimenez W., Bataller R., Arroyo V., Rodes J. A prognostic model for predicting survival in cirrhosis with ascites. J. Hepatol., 2001, 34, 46–52

    Article  PubMed  Google Scholar 

  25. Longheval G., Vereerstraeten P., Thiry P., Delhaye M., Le Moine O., Deviere J., Bourgeois N., Adler M. Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis. Liver Transpl., 2003, 9, 260–267

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gatroenterology and Hepatology Department Bulgaria, Medical University-Plovdiv, 4000, Plovdiv, Bulgaria

    Bilyana Hristova Teneva

  2. Plovdiv, Faculty of Biology Bulgaria, University of Plovdiv „Paisii Hilendarski”, 4000, Plovdiv, Bulgaria

    Emiliya Georgieva Karaslavova

Authors
  1. Bilyana Hristova Teneva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emiliya Georgieva Karaslavova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bilyana Hristova Teneva.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teneva, B.H., Karaslavova, E.G. Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine. cent.eur.j.med 9, 625–631 (2014). https://doi.org/10.2478/s11536-013-0287-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-013-0287-x

Keywords

Search

Navigation